OTC Markets OTCPK - Delayed Quote USD

Novonesis A/S (NVZMY)

67.16
+2.50
+(3.87%)
As of 1:28:08 PM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Ester Baiget President & CEO 5.96M -- 1971
Mr. Rainer Lehmann Executive VP & CFO 2.34M -- 1975
Mr. Anders Lund Chief Operating Officer 957.56k -- 1973
Mr. Claus Crone Fuglsang Chief Scientific Officer -- -- 1968
Mr. Tobias Cornelius Bjorklund Head of Investor Relations -- -- --
Mr. Tue Micheelsen Vice President of Global Sales & Marketing -- -- --
Mr. Morten Enggaard Rasmussen Executive Vice President of People & Stakeholder Relations -- -- 1976
Ms. Tina Sejersgaard Fano Executive Vice President of Planetary Health Biosolutions 942.36k -- 1969
Ms. Amy Byrick Executive Vice President of Human Health Biosolutions -- -- 1974
Mr. Henrik Joerck Nielsen Executive Vice President of Strategy & Integration -- -- 1978

Novonesis A/S

Krogshoejvej 36
Bagsvaerd, 2880
Denmark
45 44 46 00 00 https://www.novonesis.com
Full Time Employees: 
10,582

Description

Novonesis A/S produces and sells produces various industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and early lie nutrition. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, wastewater, and sewage, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novonesis A/S was founded in 1925 and is based in Bagsvaerd, Denmark.

Corporate Governance

Novonesis A/S’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 8, 2025 at 5:58 AM UTC

Novonesis A/S Earnings Date

Recent Events

April 7, 2025 at 12:00 AM UTC

Ex-Dividend Date

September 18, 2024 at 12:00 AM UTC

Dividend Date